摘要
随着经皮冠状动脉介入治疗方法在临床上得到广泛应用,急性ST段抬高性心肌梗死直接经皮冠状动脉介入治疗(PCI)的比例越来越高。但急诊PCI过程中,常常发生无复流现象,严重影响患者的预后。本文就无复流的可能机制和处理作一简要介绍。
As percutaneous coronary intervention is widely used in clinic,more and more acute ST-segment elevation myocardial infarction patients undergo direct PCI.However,no-reflow phenomenon seriously affects the prognosis of patients during emergent PCI.The possible mechanisms and therapies of no-reflow phenomenon will be introduced briefly in this review.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2011年第5期595-600,共6页
Chinese Journal of Clinical Pharmacology and Therapeutics
关键词
经皮冠状动脉介入
无复流
慢血流
血管扩张剂
血小板糖蛋白受体拮抗剂
血栓抽吸
远端保护装置
Percutaneous coronary intervention
No-reflow
Slow reflow
Vasodilator agents
Platelet glycoprotein receptor antagonist
Thrombus aspiration
Distal protection equipment